Estrigenix Therapeutics
PrivateLast Round
Seed
Jul 21, 2026
Total Funding Raised
$474,056
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Estrigenix Therapeutics operates in Healthcare & Life Sciences and is based in Wauwatosa, Wisconsin. Its latest recorded funding round was a Grant round in June 2023.
Estrigenix Therapeutics is a biotechnology company developing innovative therapies for menopausal symptoms, including hot flashes and memory dysfunction, by targeting selective estrogen receptor beta.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Estrigenix Therapeutics Comparables
Compare Estrigenix Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fervent Pharmaceuticals | 92% | |
| MenoGeniX, Inc. | 86% | |
| Tioga Pharmaceuticals | 86% |
For institutional investors. Book with your work email.
Estrigenix Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 21, 2026 | ||||
| Grant | Jun 19, 2023 | ||||
| Grant | Sep 1, 2022 | ||||
| Grant | Sep 1, 2022 | ||||
| SAFE | Jun 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Estrigenix Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wisconsin Economic Development Corporation | Grant |
| UWM Research Foundation | Grant |
| Concordia Angel Network | SAFE |
| CU Ventures | Seed |
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
Open roles increased to 3, representing 60% of headcount.
- Aug 22, 2026
Monthly visitors increased 167% MoM, reaching 3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventOct 12, 2026
Estrigenix Therapeutics, Inc. CEO Victoria Zellmer, Ph.D., joins fellow leaders at the inaugural Notre Dame Tech Forum in Illinois on Oct 5th '26 to discuss ethical business leadership, innovation, and technology's social impact.
For institutional investors. Book with your work email.
Estrigenix Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Estrigenix Therapeutics's valuation, stock price, and market status.
Is Estrigenix Therapeutics a public or private company?
Estrigenix Therapeutics is a private company.
What is the current stock price of Estrigenix Therapeutics?
Estrigenix Therapeutics is a private company, so its shares have no public market price. Caplight tracks Estrigenix Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Estrigenix Therapeutics worth (valuation)?
Valuation information for Estrigenix Therapeutics is not publicly available.
Can I buy Estrigenix Therapeutics stock?
Estrigenix Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Estrigenix Therapeutics's last funding round?
Estrigenix Therapeutics's most recent funding round was Seed on July 21, 2026.
Who are the main investors in Estrigenix Therapeutics?
Key investors in Estrigenix Therapeutics include Wisconsin Economic Development Corporation, UWM Research Foundation, Concordia Angel Network, CU Ventures, National Institute on Aging.
Will Estrigenix Therapeutics IPO soon?
No public IPO plans have been announced for Estrigenix Therapeutics.
How can I track Estrigenix Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Estrigenix Therapeutics's shares on secondary markets.